Advertisement
Advertisement
November 15, 2023
Inari Medical Completes Acquisition of LimFlow
November 15, 2023—Inari Medical, Inc. announced the close of its acquisition of LimFlow SA, a privately held company focused on limb salvage for patients with chronic limb-threatening ischemia (CLTI).
On November 1, Inari announced a definitive agreement to acquire LimFlow for a total upfront consideration of $250 million paid in cash upon closing. Contingent consideration of up to $165 million in additional cash payments is subject to the achievement of certain commercial and reimbursement milestones and will be paid out between 2025 and 2027.
“The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients suffering from CLTI,” commented Inari CEO Drew Hykes, in the company’s press release. “LimFlow addresses one of the most significant unmet needs in all of vascular medicine, is closely aligned with our mission, and adds another highly differentiated growth platform into our portfolio.”
Advertisement
Advertisement
